New Lilly Shot Reduces Body Weight by 23% in Study
PositiveFinancial Markets

- Eli Lilly's new obesity treatment shot has demonstrated a significant weight loss of 23% among patients in a recent study, positioning it as a potentially leading option in the weight-loss medication market. This development was reported by Madison Muller on Bloomberg Television.
- The promising results of this obesity shot could enhance Eli Lilly's standing in the competitive pharmaceutical landscape, particularly as it seeks to expand its portfolio in obesity treatments, which are increasingly in demand.
- This advancement comes at a time when Eli Lilly is also focusing on other treatments, such as Mounjaro for diabetes, which has recently been added to China's state insurance list, indicating the company's strategic efforts to broaden its market reach and address various health concerns.
— via World Pulse Now AI Editorial System







